Forward Citations = 555

Loading Chart...

3 inventors (with patents filed for the assignee):

Rajendra Kumar Joshi (8 out of 24 patents)

Hans-Peter Strebel (7 out of 18 patents)

Hans Peter Strebel (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 7320999 - Dimethyl fumarate for the treatment of multiple sclerosis (2008-01-22),

2. 7157423 - Fumaric acid amides (2007-01-02),

3. 6858750 - Use of fumaric acid derivatives for treating mitochondrial diseases (2005-02-22),

4. 6509376 - Utilization of dialkyfumarates (2003-01-21),

5. 6436992 - Use of fumaric acid derivatives (2002-08-20),

6. 6359003 - Use of fumaric acid derivatives in transplant medicine (2002-03-19),

7. 6355676 - Fumaric acid micro tablets (2002-03-12),

8. 6277882 - Utilization of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis (2001-08-21),

Fumapharm Ag is a biotech company specializing in the development of innovative treatments for rare diseases. With a focus on fumaric acid esters, the company is dedicated to improving the quality of life for patients worldwide. Fumapharm Ag is committed to research and development to bring new therapies to market and make a positive impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#2 in Luzern

#1,188 in Switzerland

Luzern, Switzerland

Fumapharm Ag

Forward Citations = 555

3 inventors:

Rajendra Kumar Joshi (8 out of 24 patents)

Hans-Peter Strebel (7 out of 18 patents)

Hans Peter Strebel (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com